» Articles » PMID: 8609395

Antigen Presentation by T Cells Inhibits IL-2 Production and Induces IL-4 Release Due to Altered Cognate Signals

Overview
Journal J Immunol
Date 1996 Apr 15
PMID 8609395
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Conflicting results of the effects of Ag presentation by MHC class II-expressing T cells have been described. In some studies class II-expressing T cells have been shown to act as effective APCs, while others have reported that the recognition of Ag on the surface of another T cell inactivates IL-2 production. In this study we have investigated the mechanisms involved in Ag presentation by T cells. The results obtained suggest that 1) lack of costimulation is not responsible for the inhibitory effects of T cell Ag presentation on IL-2 production; the provision of costimulation by immobilized anti-CD28 Ab or by the addition of accessory cells failed to reverse the effects of T cell Ag presentation, but restored the response to immobilized anti-CD3; 2) T cell Ag presentation induced a minimal increase in intracellular Ca2+ compared with that induced by antigen-pulsed B cells; this difference in the calcium response is not explained by quantitative differences in ligand density between B cells and T cells; and 3) despite the weak calcium signal, T cell presentation supported IL-4 release in the absence of IL-2 production. Taken together these data suggest that T cell Ag presentation leads to altered TCR/CD3-transduced signals, which biases the T cell towards a Th2 phenotype.

Citing Articles

A phase I, randomized study of combined IL-2 and therapeutic immunisation with antiretroviral therapy.

Hardy G, Imami N, Nelson M, Sullivan A, Moss R, Aasa-Chapman M J Immune Based Ther Vaccines. 2007; 5:6.

PMID: 17428345 PMC: 1864986. DOI: 10.1186/1476-8518-5-6.


Mycobacterial immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy is associated with deregulated specific T-cell responses: beneficial effect of IL-2 and GM-CSF immunotherapy.

Pires A, Nelson M, Pozniak A, Fisher M, Gazzard B, Gotch F J Immune Based Ther Vaccines. 2005; 3:7.

PMID: 16181494 PMC: 1262752. DOI: 10.1186/1476-8518-3-7.


The peripheral generation of CD4+ CD25+ regulatory T cells.

Akbar A, Taams L, Salmon M, Vukmanovic-Stejic M Immunology. 2003; 109(3):319-25.

PMID: 12807474 PMC: 1782989. DOI: 10.1046/j.1365-2567.2003.01678.x.


Identification of the neoplastically transformed cells in Marek's disease herpesvirus-induced lymphomas: recognition by the monoclonal antibody AV37.

Burgess S, Davison T J Virol. 2002; 76(14):7276-92.

PMID: 12072527 PMC: 136297. DOI: 10.1128/jvi.76.14.7276-7292.2002.


The contributions of T-cell anergy to peripheral T-cell tolerance.

Lechler R, Chai J, Lombardi G Immunology. 2001; 103(3):262-9.

PMID: 11454055 PMC: 1783252. DOI: 10.1046/j.1365-2567.2001.01250.x.